0001181431-12-040877.txt : 20120717 0001181431-12-040877.hdr.sgml : 20120717 20120717161051 ACCESSION NUMBER: 0001181431-12-040877 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120713 FILED AS OF DATE: 20120717 DATE AS OF CHANGE: 20120717 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CHESS ROBERT CENTRAL INDEX KEY: 0001227886 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24006 FILM NUMBER: 12965890 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEKTAR THERAPEUTICS CENTRAL INDEX KEY: 0000906709 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943134940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 4154825300 MAIL ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS INC DATE OF NAME CHANGE: 19980723 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS DATE OF NAME CHANGE: 19940303 4 1 rrd351029.xml TRANSACTION EXECUTED PURSUANT TO A 10B5-1 PLAN. X0306 4 2012-07-13 0 0000906709 NEKTAR THERAPEUTICS NKTR 0001227886 CHESS ROBERT C/O NEKTAR THERAPEUTICS 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 1 0 0 0 Common Stock 2012-07-13 4 M 0 24001 6.12 A 284624 D Common Stock 2012-07-13 4 S 0 24001 8.50 D 260623 D Stock Option 6.12 2012-07-13 4 M 0 24001 0 D 2007-10-31 2012-10-30 Common Stock 24001 0 D Stock option exercise and sale executed under an existing trading plan previously adopted by the Reporting Person under Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. The stock option being exercised expires on October 30, 2012. This number includes 4,914 shares held by the reporting person in his account under the issuer's 401(k) plan. The acquisition of these shares under the plan is exempt under Rule 16b-3(c). Gil M. Labrucherie, Attorney-in-Fact 2012-07-17